Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis.
Yamada S, Fujii T, Yamamoto T, Takami H, Yoshioka I, Yamaki S, Sonohara F, Shibuya K, Motoi F, Hirano S, Murakami Y, Inoue H, Hayashi M, Murotani K, Kitayama J, Ishikawa H, Kodera Y, Sekimoto M, Satoi S. Yamada S, et al. Among authors: sonohara f. Br J Surg. 2020 Dec;107(13):1811-1817. doi: 10.1002/bjs.11792. Epub 2020 Jul 7. Br J Surg. 2020. PMID: 32638367 Free PMC article. Clinical Trial.
Clinical Implications of Lysyl Oxidase-Like Protein 2 Expression in Pancreatic Cancer.
Tanaka N, Yamada S, Sonohara F, Suenaga M, Hayashi M, Takami H, Niwa Y, Hattori N, Iwata N, Kanda M, Tanaka C, Kobayashi D, Nakayama G, Koike M, Fujiwara M, Fujii T, Kodera Y. Tanaka N, et al. Among authors: sonohara f. Sci Rep. 2018 Jun 29;8(1):9846. doi: 10.1038/s41598-018-28253-9. Sci Rep. 2018. PMID: 29959362 Free PMC article.
Clinical Impact of Neoadjuvant Therapy on Nutritional Status in Pancreatic Cancer.
Tashiro M, Yamada S, Sonohara F, Takami H, Suenaga M, Hayashi M, Niwa Y, Tanaka C, Kobayashi D, Nakayama G, Koike M, Fujiwara M, Fujii T, Kodera Y. Tashiro M, et al. Among authors: sonohara f. Ann Surg Oncol. 2018 Oct;25(11):3365-3371. doi: 10.1245/s10434-018-6699-8. Epub 2018 Aug 10. Ann Surg Oncol. 2018. PMID: 30097739
Prognostic Impact of Portal System Invasion in Pancreatic Cancer Based on Image Classification.
Morimoto D, Yamada S, Murotani K, Sonohara F, Takami H, Suenaga M, Hayashi M, Niwa Y, Tashiro M, Hattori N, Iwata N, Kanda M, Tanaka C, Kobayashi D, Nakayama G, Koike M, Fujiwara M, Fujii T, Kodera Y. Morimoto D, et al. Among authors: sonohara f. Pancreas. 2018 Nov/Dec;47(10):1350-1356. doi: 10.1097/MPA.0000000000001186. Pancreas. 2018. PMID: 30286011
Tumor marker recovery rather than major pathological response is a preferable prognostic factor in patients with pancreatic ductal adenocarcinoma with preoperative therapy.
Yamada S, Yokoyama Y, Sonohara F, Yamaguchi J, Takami H, Hayashi M, Onoe S, Fujii T, Nagino M, Kodera Y. Yamada S, et al. Among authors: sonohara f. J Hepatobiliary Pancreat Sci. 2020 Aug;27(8):487-495. doi: 10.1002/jhbp.748. Epub 2020 May 14. J Hepatobiliary Pancreat Sci. 2020. PMID: 32359199
Clinical impact of additional therapy for residual pancreatic cancer.
Yamada S, Sonohara F, Tashiro M, Murotani K, Takami H, Hayashi M, Kanda M, Tanaka C, Kobayashi D, Nakayama G, Koike M, Fujii T, Kodera Y. Yamada S, et al. Among authors: sonohara f. Surg Today. 2020 May;50(5):440-448. doi: 10.1007/s00595-019-01900-y. Epub 2019 Oct 24. Surg Today. 2020. PMID: 31650262
59 results